Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2024-2028

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market 2024-2028


The PARP (Poly ADP-ribose Polymerase) inhibitors market is forecasted to grow by USD 5555.99 mn during 2023-2028, accelerating at a CAGR of 13.25% during the forecast period. The report on the PARP (Poly ADP-ribose Polymerase) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the expanded application of PARP inhibitors, ease of administration for treatment of various cancer indications, and increasing patient assistance programs.

Technavio's PARP (Poly ADP-ribose Polymerase) inhibitors market is segmented as below:

By Distribution Channel
  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies
By End-user
  • Ovarian cancer
  • Breast cancer
  • Others
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the extensive ongoing research as one of the prime reasons driving the PARP (Poly ADP-ribose Polymerase) inhibitors market growth during the next few years. Also, growing prevalence of cancer and new research areas in human genes will lead to sizable demand in the market.

The report on the PARP (Poly ADP-ribose Polymerase) inhibitors market covers the following areas:
  • Parp (Poly ADP-ribose Polymerase) inhibitors market sizing
  • Parp (Poly ADP-ribose Polymerase) inhibitors market forecast
  • Parp (Poly ADP-ribose Polymerase) inhibitors market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading PARP (Poly ADP-ribose Polymerase) inhibitors market vendors that include AbbVie Inc., Allarity Therapeutics Inc., Artios Pharma, AstraZeneca Plc, Bayer AG, BeiGene Ltd., Daiichi Sankyo Co. Ltd., Everest Pharmaceuticals Ltd., GlaxoSmithKline Plc, IMPACT Therapeutics, Jeil Pharmaceuticals Co. Ltd., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Johnson and Johnson, Karyopharm Therapeutics Inc., Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Repare Therapeutics Inc., Teva Pharmaceutical Industries Ltd., and Zai Lab Ltd.. Also, the parp (Poly ADP-ribose Polymerase) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth


  • Executive Summary
    • Market overview
      • Table Executive Summary – Chart on Market Overview
      • Table Executive Summary – Data Table on Market Overview
      • Table Executive Summary – Chart on Global Market Characteristics
      • Table Executive Summary – Chart on Market by Geography
      • Table Executive Summary – Chart on Market Segmentation by Distribution Channel
      • Table Executive Summary – Chart on Market Segmentation by End-user
      • Table Executive Summary – Chart on Incremental Growth
      • Table Executive Summary – Data Table on Incremental Growth
      • Table Executive Summary – Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global PARP (poly ADP-ribose polymerase) inhibitors market 2018 - 2022
      • Table Historic Market Size – Data Table on global PARP (poly ADP-ribose polymerase) inhibitors market 2018 - 2022 ($ million)
    • Distribution Channel Segment Analysis 2018 - 2022
      • Table Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)
    • End-user Segment Analysis 2018 - 2022
      • Table Historic Market Size – End-user Segment 2018 - 2022 ($ million)
    • Geography Segment Analysis 2018 - 2022
      • Table Historic Market Size – Geography Segment 2018 - 2022 ($ million)
    • Country Segment Analysis 2018 - 2022
      • Table Historic Market Size – Country Segment 2018 - 2022 ($ million)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2023 and 2028
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • Threat of new entrants
      • Table Threat of new entrants – Impact of key factors in 2023 and 2028
    • Threat of substitutes
      • Table Threat of substitutes – Impact of key factors in 2023 and 2028
    • Threat of rivalry
      • Table Threat of rivalry – Impact of key factors in 2023 and 2028
    • Market condition
      • Table Chart on Market condition - Five forces 2023 and 2028
  • Market Segmentation by Distribution Channel
    • Market segments
      • Table Chart on Distribution Channel - Market share 2023-2028 (%)
      • Table Data Table on Distribution Channel - Market share 2023-2028 (%)
    • Comparison by Distribution Channel
      • Table Chart on Comparison by Distribution Channel
      • Table Data Table on Comparison by Distribution Channel
    • Retail pharmacies - Market size and forecast 2023-2028
      • Table Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
    • Hospital pharmacies - Market size and forecast 2023- 2028
      • Table Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
    • Online pharmacies - Market size and forecast 2023-2028
      • Table Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Distribution Channel
      • Table Market opportunity by Distribution Channel ($ million)
      • Table Data Table on Market opportunity by Distribution Channel ($ million)
  • Market Segmentation by End-user
    • Market segments
      • Table Chart on End-user - Market share 2023-2028 (%)
      • Table Data Table on End-user - Market share 2023-2028 (%)
    • Comparison by End-user
      • Table Chart on Comparison by End-user
      • Table Data Table on Comparison by End-user
    • Ovarian cancer - Market size and forecast 2023-2028
      • Table Chart on Ovarian cancer - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Ovarian cancer - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Ovarian cancer - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Ovarian cancer - Year-over-year growth 2023-2028 (%)
    • Breast cancer - Market size and forecast 2023-2028
      • Table Chart on Breast cancer - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
    • Others - Market size and forecast 2023-2028
      • Table Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Others - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Others - Year-over-year growth 2023-2028 (%)
    • Market opportunity by End-user
      • Table Market opportunity by End-user ($ million)
      • Table Data Table on Market opportunity by End-user ($ million)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2023-2028 (%)
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2023-2028
      • Table Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Table Chart on North America - Year-over-year growth 2023-2028 (%)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Asia - Market size and forecast 2023-2028
      • Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023- 2028
      • Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Chart on US - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Table Chart on US - Year-over-year growth 2023-2028 (%)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • UK - Market size and forecast 2023-2028
      • Table Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Table Chart on UK - Year-over-year growth 2023-2028 (%)
      • Table Data Table on UK - Year-over-year growth 2023-2028 (%)
    • Canada - Market size and forecast 2023-2028
      • Table Chart on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Canada - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Chart on China - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Table Chart on China - Year-over-year growth 2023-2028 (%)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
      • Table Data Tables on Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Expanded application of PARP inhibitors
      • Ease of administration for treatment of various cancer indications
      • Increasing patient assistance programs
    • Market challenges
      • Advent of novel therapies
      • Limitations of PARP inhibitors for cancer treatment
      • Trial failures of drugs
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2023 and 2028
    • Market trends
      • Extensive ongoing research
      • Growing prevalence of cancer
      • New research areas in human genes
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Product / Service
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key offerings
    • Allarity Therapeutics Inc.
      • Table Allarity Therapeutics Inc. - Overview
      • Table Allarity Therapeutics Inc. - Product / Service
      • Table Allarity Therapeutics Inc. - Key offerings
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Overview
      • Table AstraZeneca Plc - Product / Service
      • Table AstraZeneca Plc - Key news
      • Table AstraZeneca Plc - Key offerings
    • Bayer AG
      • Table Bayer AG - Overview
      • Table Bayer AG - Business segments
      • Table Bayer AG - Key news
      • Table Bayer AG - Key offerings
      • Table Bayer AG - Segment focus
    • BeiGene Ltd.
      • Table BeiGene Ltd. - Overview
      • Table BeiGene Ltd. - Business segments
      • Table BeiGene Ltd. - Key offerings
      • Table BeiGene Ltd. - Segment focus
    • Daiichi Sankyo Co. Ltd.
      • Table Daiichi Sankyo Co. Ltd. - Overview
      • Table Daiichi Sankyo Co. Ltd. - Product / Service
      • Table Daiichi Sankyo Co. Ltd. - Key news
      • Table Daiichi Sankyo Co. Ltd. - Key offerings
    • Everest Pharmaceuticals Ltd.
      • Table Everest Pharmaceuticals Ltd. - Overview
      • Table Everest Pharmaceuticals Ltd. - Product / Service
      • Table Everest Pharmaceuticals Ltd. - Key offerings
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • IMPACT Therapeutics
      • Table IMPACT Therapeutics - Overview
      • Table IMPACT Therapeutics - Product / Service
      • Table IMPACT Therapeutics - Key offerings
    • Jeil Pharmaceuticals Co. Ltd.
      • Table Jeil Pharmaceuticals Co. Ltd. - Overview
      • Table Jeil Pharmaceuticals Co. Ltd. - Product / Service
      • Table Jeil Pharmaceuticals Co. Ltd. - Key offerings
    • Jiangsu Hengrui Pharmaceuticals Co. Ltd.
      • Table Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Overview
      • Table Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Product / Service
      • Table Jiangsu Hengrui Pharmaceuticals Co. Ltd. - Key offerings
    • Merck and Co. Inc.
      • Table Merck and Co. Inc. - Overview
      • Table Merck and Co. Inc. - Business segments
      • Table Merck and Co. Inc. - Key news
      • Table Merck and Co. Inc. - Key offerings
      • Table Merck and Co. Inc. - Segment focus
    • Ono Pharmaceutical Co. Ltd.
      • Table Ono Pharmaceutical Co. Ltd. - Overview
      • Table Ono Pharmaceutical Co. Ltd. - Product / Service
      • Table Ono Pharmaceutical Co. Ltd. - Key offerings
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
    • Zai Lab Ltd.
      • Table Zai Lab Ltd. - Overview
      • Table Zai Lab Ltd. - Product / Service
      • Table Zai Lab Ltd. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings